coIMMUNE Revenue and Competitors
Estimated Revenue & Valuation
- coIMMUNE's estimated annual revenue is currently $3.6M per year.
- coIMMUNE's estimated revenue per employee is $77,520
Employee Data
- coIMMUNE has 46 Employees.
- coIMMUNE grew their employee count by -2% last year.
coIMMUNE Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.4M | 42 | -2% | N/A | N/A |
#2 | $929.1M | 6506 | 4% | N/A | N/A |
#3 | $19.9M | 177 | 1% | N/A | N/A |
#4 | $5.4M | 63 | 9% | N/A | N/A |
#5 | $0.9M | 15 | -40% | N/A | N/A |
#6 | $18.5M | 169 | 11% | $1.8M | N/A |
#7 | $3.1M | 38 | 9% | N/A | N/A |
#8 | $16.3M | 145 | 7% | N/A | N/A |
#9 | $10.9M | 107 | 10% | N/A | N/A |
#10 | $4.9M | 53 | -2% | N/A | N/A |
What Is coIMMUNE?
CoImmune Inc. is a US company based in Durham North Carolina that was founded in 2019 based on its expertise in the development and manufacture of cell-based therapeutics to treat unmet medical needs including cancer, autoimmune and inflammatory diseases.
keywords:N/A
N/A
Total Funding
46
Number of Employees
$3.6M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
coIMMUNE's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Facility Engineer | Reveal Email/Phone |
2 | Director Quality Assurance | Reveal Email/Phone |
3 | Materials Control Associate III | Reveal Email/Phone |
4 | Director Quality Control | Reveal Email/Phone |
5 | Process Development Senior Manager | Reveal Email/Phone |
6 | Quality Assurance Specialist | Reveal Email/Phone |
7 | Sr Material Control Associate | Reveal Email/Phone |
8 | Quality Assurance Specialist III | Reveal Email/Phone |
9 | Human Resources Manager | Reveal Email/Phone |
10 | Calibration / Validation Associate | Reveal Email/Phone |
coIMMUNE News
2020-11-10 - CoImmune Closes $45 Million Series A Financing
DURHAM, N.C., Nov. 10, 2020 (GLOBE NEWSWIRE) -- CoImmune, Inc., an immuno-oncology company developing cell-based therapeutics to treat unmet medical needs in blood-borne and solid tumor indications, today announced the closing of a $45M Series A financing. CoImmune will use the proceeds from the ...
Other Companies in Durham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.1M | 46 | -19% | $2.8M |
#2 | $9.9M | 46 | -10% | N/A |
#3 | $9.9M | 46 | 7% | N/A |
#4 | $7.1M | 46 | 15% | N/A |
#5 | $8.1M | 46 | 10% | N/A |